Official announcements
Recall
|
Medicines
|
18/06/2014
The marketing authorization holder informed its supplied customers in a letter dated 17.06.2014 that aflatoxin contamination resulting from contamination of individual batches of passionflower herb was detected due to subsequent, unscheduled special…
Recall
|
Medicines
|
17/06/2014
The marketing authorization holder informed its supplied customers in a letter dated June 16, 2014, that the manufacturer cannot rule out the possibility that the solution in individual bottles is contaminated with small black particles, so that a…
Safety warnings
|
Medicines
|
04/06/2014
Update on stolen vials of Herceptin and other products, newly affected: Avastin and MabThera
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on 03.06.2014 and asked for a stock check of the affected batches.
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on 03.06.2014 and asked for a stock check of the affected batches.
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on 04.06.2014 and asked for a stock check of the affected batches.
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on June 4, 2014 and asked for a stock check of the affected batches.
Safety warnings
|
messages in brief
|
04/06/2014
Update on stolen vials of Herceptin and other products, newly affected: Avastin and MabThera
Safety warnings
|
messages in brief
|
30/05/2014
The BASG dissociates itself from statements on the homepage of the manufacturer of the unapproved drug "Reniale
Recall
|
Medicines
|
26/05/2014
In a letter dated May 26, 2014, the marketing authorization holder informed its customers that the degree of discoloration of batch 2G605A is just outside the permitted limit and the impurities are elevated. For batch 2M631A, although the degree of…
